MAP2K7 and embryonal rhabdomyosarcoma: The positive effects of MAPK p38 inhibition on the stem-like phenotype are reverted by MEK/ERK inhibition when treatment with inhibitors is concomitant, thereby demonstrating that chronic MEK/ERK inhibition strongly impairs the stem-like phenotype in embryonal rhabdomyosarcoma.